FcRn-Targeted Alpha Therapy Using [225Ac]Ac-Macropa-Rozanolixizumab Enables Potent Antitumor Activity

Molecular Imaging and Biology · Published 2026-07-15 · DOI 10.1007/s11307-026-02124-6

Authors (3)

Saba Shirin, Syed Qaiser Shah, Ralph Santos-Oliveira

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Shirin, S., Shah, S., Santos-Oliveira, R. (2026). FcRn-Targeted Alpha Therapy Using [225Ac]Ac-Macropa-Rozanolixizumab Enables Potent Antitumor Activity. Molecular Imaging and Biology. https://doi.org/10.1007/s11307-026-02124-6

Related articles